Holen Sie sich die Stockscreener-App
4.4376
19.47%
0.6876
Finanzdaten der Endra Life Sciences Inc-Aktie (NDRA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-06-30 | 2024-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
5.35%
1.3707
|
1.3011 | 1.4693 | 2.2309 | 2.7805 |
| Operating Income/Loss |
5.35%
-1.3707
|
-1.3011 | -1.4693 | -2.2309 | -2.7805 |
| Nonoperating Income/Loss |
-0.2253
|
- | - | 0.0017 | 0.00484 |
| Income/Loss From Continuing Operations Before Tax |
30.19%
-1.596
|
-1.2259 | -1.0363 | -2.2292 | -2.7757 |
| Income/Loss From Continuing Operations After Tax |
30.19%
-1.596
|
-1.2259 | -1.0363 | -2.2292 | -2.7757 |
|
Net Income/Loss
|
30.19%
-1.596
|
-1.2259 | -1.0363 | -2.2292 | 2.7757 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | 5.5514 |
| Basic Average Shares |
0.7612
|
- | - | - | - |
| Diluted Average Shares |
0.7612
|
- | - | - | - |
| Basic Earnings Per Share |
-2.10
|
- | - | - | - |
| Diluted Earnings Per Share |
-2.10
|
- | - | - | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):